Skip to content
    Fountain Healthcare Partners logo

    Fountain Healthcare Partners

    Dublin, IrelandFounded 2008
    www.fh-partners.comLinkedIn
    Biotech & Life SciencesHealthcare

    Fountain Healthcare Partners is a life science venture capital firm based in Dublin with an office in New York. Founded in 2008, it provides risk capital and expertise to entrepreneurs building specialty pharma, biopharmaceutical, medical device, and diagnostics companies across Europe and the United States.

    Deal activity decreased year-over-year (2 deals in the last 12 months vs 4 prior). Average disclosed round size is $44.7M (across 29 rounds with reported amounts).

    Find people at Fountain Healthcare Partners on Goldilocks AI

    Portfolio

    37

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    AK

    Aidan King, MBA, CFA

    Managing Partner & Co-Founder

    DM

    Dr. Manus Rogan, Ph.D, MBA

    Managing Partner & Co-Founder

    JL

    Justin Lynch, MBA

    Partner

    RM

    Ruthanne Monaghan, FCCA

    Partner & CFO

    CT

    Chris Tapper

    Senior Associate

    AF

    Annie Flynn, FCA

    Financial Controller

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    61 investments
    CompanyRoundAmountDate
    Neurent Medical logoNeurent MedicalSeries C$74MFeb 2026
    Exciva logoExcivaSeries B—Jan 2026
    NEUROMOD DEVICES LTD logoNEUROMOD DEVICES LTDSeries B—Mar 2025
    Exciva logoExcivaSeries B$59MJan 2025
    Xylocor logoXylocorSeries B$67.5MJan 2025
    XyloCor Therapeutics logoXyloCor TherapeuticsSeries B$67.5MJan 2025
    Neuromod logoNeuromodSeries B—Jan 2025
    MMedical MicroinstrumentsSeries C$110MFeb 2024
    MMedical MicroinstrumentsSeries C$110MJan 2024
    Corteria Pharmaceuticals logoCorteria PharmaceuticalsSeries A—Sep 2023
    Dualyx logoDualyxSeries A$44MMay 2023
    Neuromod logoNeuromodSeries B—Apr 2023
    CCorteriaSeries A—Jan 2023
    Dualyx logoDualyxSeries A—Jan 2023
    NeRRe Therapeutics logoNeRRe TherapeuticsUnknown—Jul 2021
    XyloCor Therapeutics logoXyloCor TherapeuticsSeries A—Mar 2021
    Calypso Biotech logoCalypso BiotechSeries A—Jan 2021
    PPriothera Ltd.Series A—Oct 2020
    IInotremSeries B—Sep 2020
    Neuromod logoNeuromodSeries B$27MJan 2020
    Calypso Biotech logoCalypso BiotechSeries A$22.6MFeb 2019
    Ermium logoErmiumSeries A—Jan 2019
    FoodMarble logoFoodMarbleSeries A—Jan 2019
    Inflazome logoInflazomeSeries B—Nov 2018
    KKaNDy TherapeuticsSeries C$32.5MAug 2018
    Page 1 of 3

    Top Co-Investors

    Enterprise Ireland10 shared
    EQT Life Sciences9 shared
    Andera Partners7 shared
    Forbion7 shared
    Novartis Venture Fund7 shared
    OrbiMed6 shared
    Omnes Capital6 shared
    Longitude Capital6 shared
    Roche Venture Fund6 shared
    Sunstone Life Science Ventures6 shared
    Amgen Ventures6 shared
    Sofinnova Partners5 shared
    Atlantic Bridge4 shared
    Silicon Valley Bank4 shared
    European Investment Bank4 shared
    Jeito Capital4 shared
    Kurma Partners4 shared
    Canaan Partners4 shared
    Gilde Healthcare3 shared
    Fidelity Management & Research Company3 shared

    Last updated: 20 October 2026